I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
K-924 Phase III Long Term Study
A Multicenter, Open-label Study to Evaluate 52 weeks long term Efficacy and Safety of K-924 in Patients with hypercholesterolemia who were treated with pitavastatin 2 mg or 4 mg.
primary prevention
cardiovascular disease
diabetes
atherosclerosis
coronary disease
- 0 views
- 16 Feb, 2024
- 13 locations
K-924 Phase III Confirmatory Study
A multicenter, active-controlled, randomized, double-blind comparative study to compare the efficacy and safety of K-924 LD tablet or K-924 HD tablet to pitavastatin 2 mg or 4 mg in patienta with hypercholesterolemia.
primary prevention
atherosclerosis
hypercholesterolemia
cardiovascular disease
pitavastatin
- 0 views
- 16 Feb, 2024
- 3 locations